GB2151942A - Plasmapheresis apparatus - Google Patents
Plasmapheresis apparatus Download PDFInfo
- Publication number
- GB2151942A GB2151942A GB08504767A GB8504767A GB2151942A GB 2151942 A GB2151942 A GB 2151942A GB 08504767 A GB08504767 A GB 08504767A GB 8504767 A GB8504767 A GB 8504767A GB 2151942 A GB2151942 A GB 2151942A
- Authority
- GB
- United Kingdom
- Prior art keywords
- channel
- filtrate
- particle mixture
- membrane
- channels
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002616 plasmapheresis Methods 0.000 title description 4
- 239000012528 membrane Substances 0.000 claims abstract description 96
- 239000002245 particle Substances 0.000 claims abstract description 94
- 239000000203 mixture Substances 0.000 claims abstract description 87
- 239000000706 filtrate Substances 0.000 claims abstract description 61
- 239000012982 microporous membrane Substances 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 5
- 239000004744 fabric Substances 0.000 claims abstract description 4
- 239000002657 fibrous material Substances 0.000 claims abstract description 4
- 238000004891 communication Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 59
- 239000008280 blood Substances 0.000 abstract description 59
- 230000003746 surface roughness Effects 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 description 12
- 239000011324 bead Substances 0.000 description 9
- 238000007789 sealing Methods 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 6
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 238000005259 measurement Methods 0.000 description 4
- 239000003607 modifier Substances 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- -1 polyethylene Polymers 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 210000003660 reticulum Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D65/00—Accessories or auxiliary operations, in general, for separation processes or apparatus using semi-permeable membranes
- B01D65/08—Prevention of membrane fouling or of concentration polarisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D25/00—Filters formed by clamping together several filtering elements or parts of such elements
- B01D25/12—Filter presses, i.e. of the plate or plate and frame type
- B01D25/172—Plate spreading means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D25/00—Filters formed by clamping together several filtering elements or parts of such elements
- B01D25/12—Filter presses, i.e. of the plate or plate and frame type
- B01D25/21—Plate and frame presses
- B01D25/215—Construction of the filter plates, frames
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/147—Microfiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/22—Controlling or regulating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/08—Flat membrane modules
- B01D63/082—Flat membrane modules comprising a stack of flat membranes
- B01D63/0822—Plate-and-frame devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2321/00—Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
- B01D2321/20—By influencing the flow
- B01D2321/2008—By influencing the flow statically
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Filtration Of Liquid (AREA)
Abstract
A device 20 for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles such as blood, said device 20 comprising housing means having a particle mixture inlet port 22, a particle mixture outlet port 26, and a filtrate outlet port 28, a microporous membrane 112 mounted within said housing means to define a particle mixture flow channel B, said channel B communicating with said port 22 and said port 26, and means 122 to define a filtrate channel P with said membrane 112 on the opposite side of said membrane 112 from said channel B and to provide flow restriction in said channel P to cause a pressure drop along the filtrate flow path, to thereby passively vary the changes in transmembrane pressure along said membrane 112. The means 122 may comprise elongated V-shaped grooves in support plates 110. Flow restriction may be produced by making the V-grooves shallower at the upstream end, by replacing the V-grooves by surface roughness or by placing flow obstructors, such as cloth or fibrous material between the membranes 112 and the plates 110. <IMAGE>
Description
1 GB 2 151942 A 1
SPECIFICATION
Adevicefor separating filtrates free of particiesfrom liquid particle mixtures The invention relatesto a device forseparating liquid filtratesfree of particles largerthan a predetermined size from liquid mixtures of the particles.
According to the invention there is provided a device for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles, said device comprising housing means having a particle mixture inlet port, a particle mixture outlet port, and a filtrate outlet port, a microporous membrane mounted within said housing means to define a particle mixture flow channel, said particle mixture flow channel being in communication with said particle mixture inlet port and said particle mixture outlet port, and means to define a filtrate channel with said microporous membrane on the opposite side of said membrane from said particle mixture flow channel and to provide flow restriction in said filtrate channel to cause a pressure drop along the filtrate flow path, to thereby passively varythe changes in transmembrane pressure along said membrane.
The device may include means to actively varythe geometry of said particle mixture flow channel or said filtrate flow channel during operation of said apparatus.
The housing means may have a particle mixture inlet - manifold, a particle mixture outlet manifold, and a filtrate outlet manifold, and said particle mixture inlet and outlet manifolds may be sufficiently large to cause pressure drops sufficiently smallerthan the pressure drop along said particle mixture flow channel to permit 20 measurements of the change in pressure along said particle mixture flow channel based upon measurements of pressure in external lines connecting to said particle mixture manifolds, said housing means and said microporous membrane being adapted to cause variation in the geometry of said particle mixture flow channel or said filtrate channel in response to the application of an external force to said housing means.
Said housing means may include an elastic shim in sealable contact with said microporous membrane to cause a decrease in the height of one of said channels when said shim is compressed.
It has been discovered that providing a microporous membrane filtration device with means to actively vary the geometry of either the particle mixture flow channel or the filtrate channel during operation provides increased versatility in varying different control parameters in the device in response to the existing 30 or desired operating conditions such as inlet flowrate, inlet particle concentration, and filtration rate, which operating conditions may vary with time or from one application to another. For example, a desired flowrate for supplying the particles mixture to the device can be maintained, and the shear rate and other control parameters can be varied to optimize the flux but avoid clogging and particle cell wall rupture simply by adjusting the height of the channel.
In preferred embodiments, the height of the particle mixture flow channel facing the membrane is varied by compressing the membrane separating device; the membrane separating device is compressed in a fixture between a front plate and a piston plate that is slidably mounted along an axis transverse to the front plate, and pressure is applied to the rear of the piston plate to vary the compression applied to the separating device; the front plate of the fixture has holes in it through which the ports for the membrane filtration device 40 pass; the fixture includes a back plate behind the piston plate, and the back plate is sealably connected to the piston plate by a diaphragm to define a pressure chamber between the back plate and the piston plate, and the back plate is fixably mounted with respect to the front plate so that increases in pressure in the pressure chamber result in compressing the filtration device between the piston plate and the front plate; the geometry of the flow channel is varied in response to changes in a control parameter of the separating 45 device; the control parameter is the pressure drop in the particle mixture channel from the inlet to the outlet; means are included to detect the pressure drop in the particle mixture channel from the inlet to the outlet, to detect the flowrate of the particle mixture into the separating device, and to maintain a proportional relationship between the pressure drop and the particle mixture flowrate by varying the height of the particle mixture channel; the proportional relationship between pressure drop and the particle mixture flowrate is maintained so long as the pressure drop is below a predetermined level, and the pressure drop is maintained at the predetermined level for increases in the particle mixture flowrate above the corresonding to the predetermined pressure drop level; the transmembrane pressure is maintained at a predetermined level by adjusting the rate of flow of the filtrate; the particle mixture inlet port is connected to an access line for a patient, and the concentrated particle mixture leaving the device is returned to the patient with a replacement fluid; the particles are formed elements; and the filtrate is plasma.
In some preferred embodiments the flow restriction means includes means with V-shaped grooves facing the membrane to provide V-shaped channels having depths that are shallower at upstream portions than downstream portions; in other preferred embodiments the flow restriction means includes means providing a surface with roughness along the filtrate channel large enough to permit flow between the surface and the 60 membrane, but small enough to provide the desired pressure drop; in other preferred embodiments the flow restriction means is a flow obstructor placed in the filtrate channel (e. g., cloth or fibrous material); there are pluralities of membranes, means to define filter channels, particle mixture flow channels, and filtrate channels, and the plurality of means to define filtrate channels are parallel plates; the housing means and microporous membranes are adapted to cause variation in the geometry of particle mixture flow channels in 65 is 2 GB 2 151 942 A 2 response to the application of an external force to the housing; the variation in geometry is variation in height; and the housing means include a shim in sealable contact with the microporous membrane.
Another embodiment of the invention also features a separating device having a membrane mounted within housing means to define a particle mixture channel and a filtrate channel. When external force is applied to the housing means, variation of the geometry of the particle mixture channel results. Also, the housing means and membrane provide particle mixture inlet and outlet manifolds that are sufficiently large to have pressure drops associated with them that are small enough to permit determining the drop in pressure in the particle mixture flow channel by taking measurements in external lines connected to the ports. In preferred embodiments there are pluralities of membranes, means to define filtrate channels, filtrate channels and particle mixture flow channels, and the plurality of means to define filtrate channels are 10 parallel plates; the housing means includes a shim in sealable contact with the microporous membrane; and the variation in geometry is variation in height.
Another embodiment of the invention features a separating device having a particle mixture channel and a filtrate channel defined by a membrane mounted between a port plate and an end plate. The peripheries of the plates are welded together, and the device is adapted to cause variation in the geometry of its particle mixture channels or its filtrate channels in response to the application of external force to the device. In preferred embodiments there are pluralities of plastic membrane support plates between the port plate and the end plate and pluralities of particle mixture channels, filtrate channels and membranes, and the peripheries of the plates are welded together; there are two membranes between each pair of membrane support plates; there is a shim to provide a sea[ with at least one membrane; and the device is adapted to cause variation in the height of the particle mixture channels in response to application of an external force to the port plate and the end plate.
Another embodiment of the invention also features a separating device having a membrane mounted within housing means to define a particle mixture channel and a filtrate channel. The housing means includes an elastic shim in sealable contact with the membrane to cause a decrease in the height of one of the channels when the shim is compressed. In preferred embodiments there are pluralities of membranes, filtrate channels, and particle mixture channels, and the housing means includes a plurality of parallel plates; and the particle mixture channel is defined by a pair of membranes separated by the elastic shim.
Another embodiment of the invention features a separating device having a pair of microporous membranes mounted within housing means to define a particle mixture flow channel between the membrane and a pair of filtrate channels, each filtrate channel being bounded on one side by a membrane. By using two membranes to define the particle mixture channel, both large-area surfaces of the particle mixture flow channel are active in separating the filtrate. In a preferred embodiment, there are pluralities of membranes, filtrate channels, and particle mixture channels, and the housing means includes a plurality of parallel plates.
The structure and operation of one presently preferred embodiment of the invention will now be described by way of example, and with reference to the drawings, in which:
Figure 1 is a schematic representation of blood cell separation apparatus according to the invention; Figure 2 is a perspective view of the separating device and a fixture of the Figure 1 apparatus; Figure 3 is a vertical sectional view, taken at 3-3 of Figure 2, of the Figure 2 fixture; Figure 4 is a horizontal sectional view, taken at 4-4 of Figure 3, of said fixture; Figure 5 is an exploded perspective view of said separating device; Figure 6 is an exploded perspective view of one set of channels of said separatory device; Figure 7 is a diagrammatic vertical sectional view of a portion of the Figure 6 set of elements; Figure 8 is a diagrammatic vertical sectional view of a portion of the Figure 6 set of elements when 45 compression has been applied to the separating device; Figure 9 is a block diagram of control electronics for the Figure 1 system; and Figure 10 is a vertical sectional view, taken at 10-10 of Figure 6, of an alternative embodient of a plate element of the Figure 5 separating device.
The construction of the embodiment will be described first, then its operation.
Referring to Figure 1, there is shown plasmapheresis apparatus 10 for separating plasma (small blood components including immunoglobulins, albumin and other proteins) from the "formed elements" (red blood cells, white blood cells and platelets) in a patient's blood and returning the formed elements to the patient with a makeup fluid. This process has utility in various applications, including therapeutically removing pathogenic substances contained in the plasma portion of a patient's blood. Apparatus 10 includes 55 blood inflow line 12 and blood return line 14, for connection to lines attached to the patient. Line 12 has pressure sensor 15 and associated drip chamber 17 upstream of peristaltic blood pump 16 to monitor the blood pressure in the access line 12. Also connected to line 12 is a supply of anticoagulant (not shown).
Downstream of pump 16 is blood inlet drip chamber 18 and its associated pressure sensor 19. Formed element separating device 20 has blood inlet port 22 (for receiving whole blood from the patient), blood outlet port 26, and plasma filtrate port 28. Blood inlet port 22 is connected by line 24 to the outlet of drip chamber 18. Plasma port 28 is connected by line 30 to plasma drip chamber 32, peristaltic plasma pump 34, and plasma collection bag 36. Plasma drip chamber 32 has pressure sensor 37 associated with it. Separator is held within clamping fixture 38, described in detail below, which compresses device 20 to vary the height of the blood channels within it by means of pressure supplied by pressure source 40, which is a 65 3 C' B 2 151 942 A 3 pressure chamber with a piston driven by a threaded rod connected to a control motor. Device 38 has valve 41 for air bleeding. Blood outlet port 26 is connected byline 42 to junction 44, to which replacement fluid from replacement reservoir 46 is pumped by peristaltic pump 48. Junction 44 is connected by line 47 to return drip chamber 43, having associated pressure sensor 50. The outlet of drip chamber 43 is connected to 5 air bubble detector 52 and patient return line 14.
Referring to Figure 2, separating device 20 is shown mounted within clamping fixture 38. Ports 22, 26, 28 extend through holes in front plate 54, which is vertically slidably mounted between side supports 56, 57. Device 20 is held against front plate 54 by piston plate 58 shown partially extending beyond cover plate 60.
Referring to Figure 3, it is seen that piston plate 68 has circular piston projections 62, 64 extending from its rear surface. Rolling diaphragms 66, 68 are connected to the faces of piston projections 62, 64 by screws 70, 10 72 and circular retainers 74, 76, respectively. The peripheries of diaphragms 66, 68 are sealably sandwiched between bonnets 78, 80 and the inner surface of back plate 82. Back plate 82 has cylindrical depressions 84, 86 for receiving the two piston projections and their associated retainers. Female swivel connection 88, for connection to pressure source 40, communicates with depression 86, and air bleeding valve 41 communicates with depression 84. Channel 90 provides communication between depressions 84,86. 15 Referring to Figure 4, it is seen that front plate 54 has a pair of V- shaped grooves 92 for mating with V-shaped projections 94 extending rearwardly from transverse extensions of side supports 56, 57. Pins 96 extend inwardly from side supports 56, 57, and their unsupported ends are within vertical grooves 98, which run along the sides of front plate 54. Portions of bonnet 78, the periphery of diaphragm 66, and the associated periphery of back plate 82 are shown within recesses 100, 102 in side supports 56, 57.
Referring to Figure 5, there is shown an exploded view of separating device 20. Blood inlet port 22, blood outlet port 26, and plasma outlet port 28 are formed on the front of plastics port plate 104. Between port plate 104 and end plate 106 are six sets 108 of plasma-blood-plasma channels (only three sets are shown in Figure 5), each set 108 including two membrane support plates 110, two plastics, microporous membranes 112 (approximately 0.17 mm thick, and having an average pore size of 0.6 micron) and 1.02 x 10-4M (0.004 inch) 25 thick polyethylene shim 114 between membranes 112. Adjacent plasma-blood- plasma channel sets 108 share a common membrane support plate 110. Referring to Figure 6, the plates, membranes, and shim for one set 108 of the channels are shown. Blood channels B are provided between membranes 112, and plasma channels P are provided between membrane support plates 110 and membranes 112. Each membrane plate 110 is made of acrylonitrile butacliene styrene (ABS), and is approximately 2.90 x 10-3M (0.114 inch) thick, 30 0.22m (8 3/4 inches) long, and 0.083m (3 1/4 inches) wide. Holes 116 in plates 110 and holes 130 in membranes 112 are aligned with inlet port 22 to provide for the flow of incoming blood from inlet port 22 to all of blood channels B in channel sets 108. Holes 118 in plates 110 are similarly aligned with blood outlet port 26 and holes 132 in membranes 112 to provide for flow of the concentrated formed element mixture from blood channels B to outlet port 26. Holes 120 in plates 110 are aligned with plasma outlet port 28 and 35 holes 134 in membranes 112 to provide for flow of plasma from plasma filtrate channels P to plasma outlet port 28.
On both the upper and lower surfaces of plates 110 are a plurality of elongated V-shaped grooves 122, which are separated by three parallel ribs 124. Around the perimeters of upper and lower surfaces 123 of plates 110, encompassing holes 116,118,120 and grooves 122, are continuous sealing beads 126, which each 40 has a hemispherical cross-section of approximately 1.3 X 10-4M (0.005 inch) radius and extends above or below the planes of surfaces 123 of plate 110. As can be seen from Figure 7 and 8, beads 126 on the upper and lower surfaces are not aligned with each other. Similar continuous sealing beads 133 surround holes 120 on plate 110. V-shaped grooves 122 are formed by surfaces making 45' angles with surface 123 and are approximately 1.02 x 10-3M (0.04 inch) wide and 5.08 x 10-4 (0.02 inch) deep. Tips 125 of plate portions between adjacent grooves 122 (Figure 7 and 8) are approximately 7.6 x 10- 'm (0.003 inch) above or below surfaces 123. The upper surfaces of ribs 124 are atthe same level as surface 123. Grooves 122 end near plasma outlet port 120 attransverse plasma outlet channel 128, which collects plasma from the grooves and directs it to elbow channel 129, which passes under sealing beads 133 and communicates with the interior of-' plasma outlet hole 120 between outer surfaces 123. On the longitudinal ends of plate 110 are holes 180 and 50 protuberances 182 for mating with corresponding protuberances and holes on adjacent plates to provide alignment during assembly.
When assembled, portions of membranes 112 surrounding holes 130 and 132 are heat-sealed to facing portions of plates 110 to provide inlet and outlet blood manifold seals and prevent leakage between the blood and plasma channels. Plates 110, membranes 112, and shims 114 are brought together. Sealing beads 55 126 provide a good sea[ between shims 114, membranes 112 and plates 110. The peripheries of the plates are welded together so that melted ABS from adjacent plates 110 mix together. As can be seen in Figure 7 and 8, the edges of membranes 112 and shims 114 are inside the edges of plates 110. At the ends of the stack, melted plastics materials from port plate 104 and end plate 106 and the adjacent support plates 110 similarly mixes together, thus connecting and sealing the entire stacktogetherto form device 20. Portions of 60 membranes 112 surrounding holes 134 are squeezed by continuous sealing beads 133 formed on the surfaces of plates 110 around holes 120 to provide plasma outlet channels isolated from blood outlet holes 118. Although holes 135, transverse channels 139, elbow channels 137, and sealing beads 141 (which are similarto holes 120, transverse channels 128, elbow channels 129, and sealing beads 133) are provided on the inlet side of plate 110 for ease of manufacture and assembly, there is no hole in port plate 104 4 GB 2 151 942 A 4 corresponding to plasma port 128; thus, plasma collected in Wgrooves 122 is directed to holes 120 communicating with plasma outlet port 28.
Port plate 104, end plate 106, membrane support plates 110 and shim 114 all act together a housing means to define the plasma and blood channels with microporous membrane 112.
A blood inlet manifold distributing blood from inlet port 22 to channels B is provided by holes 116, 5 membranes 112, holes 130, and the semicircular and triangular depressions formed in the surfaces of plates around holes 116. A blood outlet manifold is similarly provided by holes 118, membranes 112, holes 132 and the semicircular and triangular depressions formed in the surfaces of plates 110 around holes 118. Both of these manifolds are suff iciently large to cause pressure drops suff iciently smaller than the pressure drop along blood flow channels B to permit determination of the change in pressure along the blood flow channels based upon measurements of pressure in external lines connected to the blood inlet and outlet ports.
The operation of the embodiment will now be described. In operation, blood access line 12 and return line 14 are connected to the patient. Incoming blood travels through line 12, pump 16, and line 24to inlet port 22 of separating device 20. Blood flows through holes 116 of plates 110 and holes 130 of membranes 112 and 15 enters blood channels -B between membranes 112. Because of the seals of portions of membranes 112 surrounding membrane holes 130to facing portions of plates 110 surrounding holes 116, there is no flow of incoming blood to the plasma sides of membranes 112 facing plates 110, unless it passes through membranes 112.
Normally the pressure in blood channels B is higher than the pressure is plasma channels Pon the other 20 sides of membranes 112, and this causes membranes 112 to be forced against tips 125 of plates 110, thereby forming blood channels B. Components of the blood that are smaller than the pores of membranes 112 pass through membranes 112 and flow down the channels formed by V-grooves 122 and the facing surfaces of membranes 112 to transverse outlet channel 128, elbow channel 129, and plasma outlet holes 120 in plate 110. Because of the pressure seal between sealing beads 133 and portions of membrane 112 surrounding 25 holes 134, there is no leakage between plasma channels P and blood channels B. The formed elements, which are larger than the pores of membrane 112, an other components which did not pass through membranes 112, flow to blood outlet holes 132 in membrandii 112 and holes 118 in plates 110. One again, the heat seals between portions of membranes 112 surrounding holes 132 and portions of plate 110 surrounding holes 118 preventthe leakage of formed elements into the plasma channels P. There is 30 a gradual depression in plates 110 in portions surrounding holes 116,118, and the blood pressure forces corresponding portions of membrane 112 against plates 110. Channels 128 are thin enough, and membranes 112 are rigid enough, to prevent blockage of channels 128 by membranes 112 at the pressures used.
Referring to Figure 1, the plasma filtrate from port 28 flows through line 30, drip chamber 32, and pump 34 to plasma collection reservoir36. The concentrated formed element mixture from outlet port 26 flows 35 through line 42 to junction 44, where replacement fluid from reservoir 46 is added. The makeup fluid from reservoir46 is supplied to junction 44 by pump 48 at a controlled rate depending upon the particular patient and the setting of the control electronics for pump 48. For example, the makeup fluid could be pumped at a rate faster than plasma removal when it is desired to give the patient excess fluid to keep his blood pressure high to avoid problems associated with low blood pressure. The makeup fluid could also, in some instances, 40 be pumped at a rate slower than plasma removal. The concentrated formed element mixture and makeup fluid flow through line 47, drip chamber 43, and air bubble sensor 52 to return line 14, and from thereto the patient.
During plasmapheresis, pump 16 is operated to cause blood flow at a desired rater often the maximum rate achievable without deleterious effects to the particular patient or collapsing of the blood vessel that blood is being removed from. The shear rate can then be maintained at a desired level (i.e., high enough to avoid pore clogging but low enough to avoid hemolysis) by adjusting the height between membranes 112 and blood channels B by controlling the compression applied to separating device 20 by fixture 38.
The following equation describes shear rate, SR, forfully developed flow of a Newtonian fluid in a rectangular channel were the width is suff iciently large in comparison to the height so that end effects can be 50 neglected.
6Q 6 ( Qk) 113 (A p) 213 SR = F7W_ W. 12 ul 55 where: Q = flowrate of fluid in the rectangular channel, w = width of the channel, h height of the channel, 1 length of the channel, Ap pressure drop down the channel, and u =viscosity of the fluid. It is seen from the first equivalence presented by Equation (1) thatthe shear rate is directly proportional to the flow of blood and inversely proportional to the square of height H of the channel. The second GB 2 151942 A 5 equivalence presented in Equation (1) showsthatthe pressure drop down the channel is related to, and is therefore a measure of, the shear rate and the channel height.
Figure 7 shows a channel B when the pressure from source 40 is low, and blood flow is relatively high. Figure 8 shows the same channel when blood flow has decreased to a point that would require that blood channel height H be decreased to maintain the desired shear rate for the new conditions. This is done by increasing the pressure from source 40, which causes an increase in pressure between back plate 82 and piston plate 58 and the moving of plate 58 to the right (Figure 4), thereby compressing separating device 20 between plate 58 and front plate 54. Some of the compression is taken up by membranes 112, and some of the compression is taken up by shims 114 and plastics plates 110. Because membranes 112 are already supported by tips 125, changes in thickness of the device 20 result in changing height H between membranes10 112. This change in device thickness and thus channel height is controlled by apparatus 10 by monitoring and controlling the pressure drop down blood channels B. In Figure 9, there is shown control electronics 160 for carrying out a particular protocol for operating apparatus 10. According to this protocol, height H is varied to result in a drop in pressure, AP, from blood inlet port 22 to blood outlet port 26 according to Equations (2) and (3):
AP = [1.0 m m Hg/ml/m in] X QB, for 40:s Qi3: 100 m I/min AP = 100 mm hg, fo r 160 2t Q13 z: 100 m 1/m i n (2) (3) where:
QB is the total flow of blood into separating device 20.
Thetransmembrane pressure (TMP) nearthe outlet end of membranes 112 is maintained at22 mm Hg, unless the plasma flow rate, Qp, increases to 0.6 of QB while trying to achieve a TIVIP of 25 mm Hq. In that case, Gp will be limited to 0.6 Of QB. The value of 25 mm Hq has been selected as the outlet TIVIP because it results in a flux through membranes 112 that is acceptable at the same time that the transmembrane pressure near the inlet is kept at or below 125 mm Hg, which is not high enough to cause hemolysis or clogging of the pores. (The pressure in plasma channels P remains substantially constant along their lengths.) In carrying out the above-described protocol, A P control signal generator 162 receives signals from blood pump 16 indicating total blood flow QB into device 20 and provides control signal A P', indicating the desired 30 pressure drop through blood channels B to comparator 166 according to Equations (2) and (3). Subtracter 164 receives signals from blood pressure sensor 19 indicating the pressure of the blood at inlet 22 of device and signals from return pressure sensor 50 indicating the pressure of the concentrated formed element mixture leaving channels B at port 26 and provides a signal, A P, indicated the actual drop in pressure along channels B to comparator 166. if A P' equals A P, comparator 166 provides signals to the motor of pressure 35 source 40 to maintain the pressure in fixture 38 at its present level to maintain heights H in the blood channels B at the present value.
If A P'exceeds A P by more than a predetermined value, comparator 166 sends signals to the motorfor source 40 to increase the pressure in fixture 38 to decrease heights H so thatthe actual pressure drop,A P, will be increased to equal A P'. If A P' is less than A P by more than a predetermined value, comparator 166 40 sends signals to the motor for source 40 to decrease the pressure in fixture 38 to result in increasing heights H in channels B. Pressure source 40 is monitored and controlled to prevent the pressure source 38 from exceeding safe pressure limits.
Subtractor 168 receives signals from return pressure sensor 50 indicating pressure in the concentrated formed element mixture leaving channels Batport 26 and signals from plasma pressure sensor 37 indicating 45 the pressure of the plasma in device 20 and provides an output signal, TIVIP, indicating the actual transmembrane pressure near the outlet end of separating device 20. Control 0 signal generator 172 (0 is defined as Qp1QB) receives signals from blood pump 16 indicating the flow of blood into device 20, QB, and signals from plasma pump 34 indicating the flow of plasma, Qp, through the membranes and out of device 20, and provides control signal CS to TIVIP signal modifier 170. As QP approaches 0.6 of QB, signal CS informs the TIVIP signal modifier 170, and TIVIP signal modifier 170 drives the plasma pump 34 so that Qp does not exceed 0.6 QB. If Qp does not approach 0.6 Of QB, the TIVIP signal modifier drives the plasma pump 34 so that the desired TIVIP is achieved.
The formed element containing mixture need not be whole blood as in plasmapheresis as described above; it could be red blood cells, white blood cells, and/or platelets which have been separated from whole 55 blood and frozen in an electrolyte solution. Similarly, the invention is not limited to separating formed elements, but also has application in separating bacteria or cultures of other cells (e.g., liver cells), which one wants to avoid destroying in the process of separating, and to separating precipitates or any other particles of sizes greater than the pore size from liquid mixtures of the particles.
In addition to varying the height of channels, the channel geometry can be actively varied by varying the 60 width (from Equation (1) it is seen that shear rate varies with both height and width for a rectangular channel) or the shape of the channels; e.g., one can compress the sides of a separating device to increase the channel height and decrease the channel width, or one can provide movable partitions to variably define the flow channels.
6 GB 2 151942 A 6 The geometry of the particle mixture channels (e.g., blood flow channels B) can be varied uniformly down the channels in response to other control protocols in addition to or in place of the maintenance of a proportional relationship between the pressure drop A P down the particle mixture channel and the flow of blood into the particle mixture channel described above. The other protocols can involve making control parameters of any of the following operating conditions: the pressure drop down the particle mixture 5 channels, the pressure drop down the filtrate channels, the flow of the particle mixture, the particle concentration, the transmembrane pressure, and the flux.
Also, the geometry of the channels can be actively or passively varied along their lengths to optimize the separation as a function of location along the membranes. This is desirable because the flowrate and particle concentrations are different at different points along the membranes, and, associated with these different 10 flowrates and particle concentratons, are optimal transmembrane pressures, velocity profiles (perpendicular to the membrane), and particle concentration profiles (perpendicular to the membrane) for achieving the desired filtration rate while avoiding plugging and particle destruction. One way of achieving this optimization is actively varying the particle mixture channel geometry along the entire channel in response to such operating conditions as the f lowrate of the particle mixture, the concentration of particles, the flux, 15 the pressure drop in the particle mixture channel, the pressure drop in the filtrate channel, the transmembrane pressure profile along the membrane, the velocity profile in the particle mixture, and the concentration profile in the particle mixture. The operating conditions used become the control parameters for the protocols. Another way to effect at least some of the desired results is to passively vary the geometry of the filtrate channel to cause a desired pressure gradient in the filtrate channel, as is described in detail 20 below. Also, one can actively vary the geometry of the filtrate channel in response to the operating conditions. (One way of varying the filtrate channel geometry is providing V-grooves by an accordian like member that can be expanded or contracted.) Changes in the filtrate channel geometry cause changes in the filtrate pressure, in turn affecting the TIVIP, in turn affecting the operation conditions in the particle mixture channel. Thus, the desired pressure gradient in the filtrate channel is the gradient which in conjunction with 25 the pressure gradient in the particle mixture channel gives the preferred TIVIP and other operating conditions. These geometry changes in the particle mixture flow channel and the filtrate channel can be used together or independently.
By placing flow restriction means within the filtrate flow paths between the membranes and support plates, one can passively achieve pressure drops along the filtrate flow paths that approximate those along 30 the blood channel flow paths, thereby permitting the use of higher velocity gradients in the particle mixture flow channel, thus permitting a high flux along the entire length of the membrane. This flow resistance can be provided by making the V-grooves shallower at the upstream end, where the flow is smaller, as is disclosed in Figure 10. Flow resistance can also be provided by replacing the V-grooves with surface roughness of high enough magnitude to permit flow but of low enough magnitude to provide the desired 35 pressure drop, or by placing flow obstructors, such as cloth or fibrous material, between the membranes and the membrane support plate. Also, the flow restriction can be such that, instead of providing a pressure drop approximating that in the blood channel flow path, one could provide a pressure drop to change the TIVIP along the membrane depending upon the concentration of formed elements or other operating conditions.
Also, the transmembrane pressure can be maintained by varying the flow of the particle mixture in addition to varying the filtrate pump, and can also be varied by varying the heights of the particle mixture channels. Other microporous membranes will work, and shims 114 can be avoided by providing for the desired blood channel depth by making tips 125 of Wgrooves 122 lower in relation to surface 123.
Separating device 20 can contain any number of plasma-blood-plasma channel sets 108, or even just a plasma channel separated from a blood channel by a single membrane. If only a single plasma-bloodplasma channel set 108 is desired, membrane support plates 110 are not required; membrane supporting V-grooves 122 can be provided on the interior surfaces of port plate 104 and end plate 106, which can be welded together as adjacent plates 110 are shown welded together in Figures 7 and 8.
In addition to compressing device 20 between front plate 54 and piston plate 58, device 20 could be secured to these plates, and a vacuum could be applied to depressions 84, 86 to expand device 20 to vary 50 heights H of blood channels B. The entire separating device need not be compressed, a bellows type device could be incorporated between port plate 104 and end plate 106 to compress the remainder of the housing means (i.e., shims 114, support plates 110 and membranes 112) to vary the heights of the particle mixture channels.
In place of the.004 inch thick polyethylene shim 114 one can use a thicker shim or one made of a more 55 elastic material, e.g., rubber, to provide a more compliant device to permit larger changes in the channel height H.
7 GB 2 151942 A 7
Claims (10)
1. A device for separating a liquid filtrate free of particles larger than a predetermined size from a liquid mixture of said particles, said device comprising housing means having a particle mixture inlet port, a particle mixture outlet port, and a filtrate outlet port, a microporous membrane mounted within said housing 5 means to define a particle mixture flow channel, said particle mixture flow channel being in communication with said particle mixture inlet port and said particle mixture outlet port, and means to define a filtrate channel with said microporous membrane on the opposite side of said membrane from said particle mixture flow channel and to provide flow restriction in said filtrate channel 'Lo cause a pressure drop along the filtrate flow path, to thereby passively varythe changes in transmembrane pressure along said membrane. 10
2. A device according to claim 1, wherein said filtrate channel means includes means with V-shaped grooves facing said membrane to provide V-shaped channels covered by said membrane, the depths of said grooves being shallower at upstream portions than downstream portions to provide said pressure drop.
3. A device according to claim 1, wherein said filtrate channel means includes means providing a surface with roughness along said filtrate channel large enough to permitflow between said surface and said 15 membrane but small enough to provide said pressure drop.
4. A device according to claim 1, wherein a flow obstruction is within said filtrate channel to provide said pressure drop.
5. A device according to claim 4, wherein said flow obstruction is apiece of cloth material.
6. A device according to claim 4, wherein said flow obstruction is fibrous material.
7. A device according to claim 1, wherein said housing means and said microporous membrane are adapted to cause variation in the geometry of said particle mixture flow channel in response to the application of an external force to said housing means.
8. A device according to claim 1 in which there are pluralities of membranes, means to define filtrate channels, filtrate channels, and particles mixture flow channels, said plurality of means to define filtrate 25 channels being a plurality of parallel plates.
9. A device according to claim 1, wherein said housing means includes a shim in sealable contact with said microporous membrane.
10. A device according to claim 7, wherein said variation in geometry is variation in height.
Printed in the UK for HMSO, D8818935, 6185, 7102. Published by The Patent Office, 25 Southampton Buildings, London, WC2A lAY, from which copies may be obtained.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30748981A | 1981-10-01 | 1981-10-01 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8504767D0 GB8504767D0 (en) | 1985-03-27 |
GB2151942A true GB2151942A (en) | 1985-07-31 |
GB2151942B GB2151942B (en) | 1986-01-02 |
Family
ID=23189998
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08227714A Expired GB2112293B (en) | 1981-10-01 | 1982-09-29 | Plasmapheresis apparatus |
GB08504767A Expired GB2151942B (en) | 1981-10-01 | 1985-02-25 | Plasmapheresis apparatus |
GB08504768A Expired GB2151943B (en) | 1981-10-01 | 1985-02-25 | Plasmapheresis apparatus |
GB08504766A Expired GB2151941B (en) | 1981-10-01 | 1985-02-25 | Holding and compressing device for plasmapheresis apparatus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08227714A Expired GB2112293B (en) | 1981-10-01 | 1982-09-29 | Plasmapheresis apparatus |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08504768A Expired GB2151943B (en) | 1981-10-01 | 1985-02-25 | Plasmapheresis apparatus |
GB08504766A Expired GB2151941B (en) | 1981-10-01 | 1985-02-25 | Holding and compressing device for plasmapheresis apparatus |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS5870810A (en) |
CA (1) | CA1198686A (en) |
DE (1) | DE3236310A1 (en) |
FR (1) | FR2513896A1 (en) |
GB (4) | GB2112293B (en) |
IT (1) | IT1152566B (en) |
NL (1) | NL8202703A (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980068A (en) * | 1983-08-15 | 1990-12-25 | Lavender Ardis R | System, apparatus and method for continuously fractionating blood in situ |
US4980054A (en) * | 1983-08-15 | 1990-12-25 | Lavender Ardis R | System and method for mass transfer between fluids |
JPS60183008A (en) * | 1984-03-02 | 1985-09-18 | Shokuhin Sangyo Maku Riyou Gijutsu Kenkyu Kumiai | Membrane separation apparatus |
JPS6145772A (en) * | 1984-08-07 | 1986-03-05 | テルモ株式会社 | Serum separating method and apparatus |
FR2581316A1 (en) * | 1985-05-02 | 1986-11-07 | Murisasco Antoine | Method and device for automatic plasma exchanges controlled by an integrated computer |
EP0208061A1 (en) * | 1985-05-14 | 1987-01-14 | Biotest Pharma GmbH | Method and device for obtaining blood plasma |
EP0341573A3 (en) * | 1988-05-13 | 1990-05-09 | Sartorius Ag | Process and apparatus for the cross-flow filtration of liquids |
FR2691911B1 (en) * | 1992-06-05 | 1994-11-25 | Delmas Olivier | Device for obtaining a supernatant of activated thrombocytes, process using the device and obtained supernatant. |
GB9224468D0 (en) * | 1992-11-23 | 1993-01-13 | Bio Flo Ltd | Fluid treatment system |
GB2305370B (en) * | 1995-09-19 | 1997-10-29 | Asahi Medical Co | Device for depletion of leukocytes |
ATE553835T1 (en) * | 2001-09-20 | 2012-05-15 | Emd Millipore Corp | FILTER MODULE |
ES2356811T3 (en) * | 2001-09-20 | 2011-04-13 | Millipore Corporation | ELEMENT OF FLUID TRAVEL CONTROL FOR A FLUID TREATMENT MODULE. |
EP2785429A4 (en) | 2011-11-30 | 2015-10-28 | Wellstat Diagnostics Llc | Filtration module |
US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
US9950321B2 (en) | 2014-08-04 | 2018-04-24 | General Electric Company | Device for separation and collection of plasma |
US10335078B2 (en) | 2014-08-04 | 2019-07-02 | General Electric Company | Device for separation and collection of plasma |
WO2016153428A1 (en) * | 2015-03-23 | 2016-09-29 | Nanyang Technological University | Flow cell apparatus and method of analysing biofilm development |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK434874A (en) * | 1974-08-14 | 1976-02-15 | Danske Mejeriers Maskinfabrik | FILTERING DEVICE |
SE396017B (en) * | 1974-12-23 | 1977-09-05 | Alfa Laval Ab | FILTRATION PROCEDURE, SPECIAL FOR ULTRA FILTRATION |
US4191182A (en) * | 1977-09-23 | 1980-03-04 | Hemotherapy Inc. | Method and apparatus for continuous plasmaphersis |
US4212742A (en) * | 1978-05-25 | 1980-07-15 | United States Of America | Filtration apparatus for separating blood cell-containing liquid suspensions |
DE2823057A1 (en) * | 1978-05-26 | 1979-11-29 | Bayer Ag | Semipermeable membrane unit - having set of spacers and membrane with appropriate holes which can be combined in modular form |
IL58787A0 (en) * | 1978-12-21 | 1980-02-29 | Baxter Travenol Lab | Disposable filter cell for membrane plasmapheresis |
DE2925143C2 (en) * | 1979-06-22 | 1983-11-17 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Device for continuous plasmapheresis |
US4318813A (en) * | 1980-06-30 | 1982-03-09 | Baxter Travenol Laboratories, Inc. | Membrane plasmapheresis module |
JPS5935631B2 (en) * | 1980-07-24 | 1984-08-29 | テルモ株式会社 | Body fluid “filtration” device |
NZ198268A (en) * | 1980-09-03 | 1984-03-30 | Memtech Lab Pty Ltd | Removal of micron and sub-micron particles from fluid |
BR8207763A (en) * | 1981-06-25 | 1983-07-19 | Baxter Travenol Lab | MEMBRANE PLASMAPHERESIS APPARATUS AND PROCESS USING A FLUID FLOW CONTROLLER DEVICE TO STABILIZE TRANSMEMBRANE PRESSURE |
-
1982
- 1982-07-06 NL NL8202703A patent/NL8202703A/en not_active Application Discontinuation
- 1982-07-07 CA CA000406756A patent/CA1198686A/en not_active Expired
- 1982-09-14 IT IT23249/82A patent/IT1152566B/en active
- 1982-09-28 FR FR8216315A patent/FR2513896A1/en not_active Withdrawn
- 1982-09-29 GB GB08227714A patent/GB2112293B/en not_active Expired
- 1982-09-30 DE DE19823236310 patent/DE3236310A1/en not_active Withdrawn
- 1982-10-01 JP JP57173108A patent/JPS5870810A/en active Pending
-
1985
- 1985-02-25 GB GB08504767A patent/GB2151942B/en not_active Expired
- 1985-02-25 GB GB08504768A patent/GB2151943B/en not_active Expired
- 1985-02-25 GB GB08504766A patent/GB2151941B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2151943B (en) | 1986-01-02 |
GB8504767D0 (en) | 1985-03-27 |
GB8504768D0 (en) | 1985-03-27 |
IT8223249A0 (en) | 1982-09-14 |
IT1152566B (en) | 1987-01-07 |
GB2151942B (en) | 1986-01-02 |
DE3236310A1 (en) | 1983-04-21 |
GB2112293B (en) | 1986-01-02 |
GB8504766D0 (en) | 1985-03-27 |
JPS5870810A (en) | 1983-04-27 |
CA1198686A (en) | 1985-12-31 |
GB2151941A (en) | 1985-07-31 |
GB2112293A (en) | 1983-07-20 |
GB2151941B (en) | 1986-01-02 |
GB2151943A (en) | 1985-07-31 |
FR2513896A1 (en) | 1983-04-08 |
NL8202703A (en) | 1983-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2151942A (en) | Plasmapheresis apparatus | |
US4735726A (en) | Plasmapheresis by reciprocatory pulsatile filtration | |
US4798090A (en) | Apparatus for use with fluid flow transfer device | |
US4666598A (en) | Apparatus for use with fluid flow transfer device | |
US4770787A (en) | Method of operating a fluid flow transfer device | |
US4963260A (en) | Liquid filtering device | |
US4936980A (en) | Apparatus and method for plasma separation | |
JP3395911B2 (en) | Cross-flow filter device with pressure balancing equipment | |
US8337700B1 (en) | High capacity biological fluid filtration apparatus | |
US7270757B1 (en) | High capacity gravity feed filter for filtering blood and blood products | |
US4228015A (en) | Plasma treatment apparatus | |
US4746436A (en) | Membrane plasmapheresis apparatus and process which utilize a flexible wall to variably restrict the flow of plasma filtrate and thereby stabilize transmembrane pressure | |
US4636312A (en) | Plasmapheresis filtration module having improved end plate | |
EP0070738B1 (en) | Plasmapheresis by reciprocatory pulsatile filtration | |
GB2037614A (en) | Disposable filter cell for membrane plasmapheresis | |
EP2445616B1 (en) | Simulator device | |
EP0082187B1 (en) | Membrane plasmapheresis apparatus | |
EP0387270A1 (en) | Transfer membrane apparatus. | |
CA1252737A (en) | Plasmapheresis filtration module | |
US4640776A (en) | Plasmapheresis filtration module having pressure balancing and sealing means | |
CN216909888U (en) | Trace tangential flow plate type membrane test equipment | |
Willinger et al. | Microspheres based detoxification system: in vitro study and mathematical estimation of filter performance | |
EP0089434A2 (en) | Plasmapheresis filtration module | |
CA1269620A (en) | Plasmapheresis by reciprocatory pulsatile filtration | |
CA1308569C (en) | Pressure sensing apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |